Yi Zhang

Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction
202322 citationsauthor #4
Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells
202333 citationsauthor #9
Circular RNA hsa_circ_0002938 (circCRIM1) promotes the progression of esophageal squamous cell carcinoma by upregulating transcription factor 12.
20235 citationsauthor #7
Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors.
20238 citationsauthor #2
Correction: miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma
20232 citationsauthor #20
Immunosenescence: molecular mechanisms and diseases
2023624 citationsauthor #9
S234: UPDATED CLINICAL RESULTS OF FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA
20230 citationsauthor #18
High mobility group protein B1 decreases surface localization of PD-1 to augment T-cell activation.
202215 citationsauthor #13
m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer
202236 citationsauthor #11
Long-term clinical efficacy of cytokine-induced killer cell-based immunotherapy in early-stage esophageal squamous cell carcinoma.
20224 citationsauthor #15
Clinical Correlation of Function and TCR vβ Diversity of MAGE-C2–Specific CD8+ T Cell Response in Esophageal Cancer
20224 citationsauthor #11
Corrigendum to "Docetaxel downregulates PD-1 expression via STAT3 in Tlymphocytes" [Clinical Lung Cancer 19 (2018) e675-e683].
20220 citationsauthor #6
Intratumor microbiome in cancer progression: current developments, challenges and future trends
202257 citationsauthor #2
Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
202211 citationsauthor #6
Intratumor microbiome in cancer progression: current developments, challenges and future trends
20220 citationsauthor #2
CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy
202238 citationsauthor #10
Adjuvant cytokine-induced killer cell immunotherapy improves long-term survival in patients with stage I-II non-small cell lung cancer after curative surgery.
20224 citationsauthor #9
Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8^+ T cell function
202242 citationsauthor #11
Expression Of Concern
20220 citationsauthor #12
Corrigendum to "Regulatory T cells were recruited by CCL3 to promote cryo-injured muscle repair" [Immunol. Lett. 204 (2018) 29-37]✰.
20220 citationsauthor #11
IL‐33/ST2 as a potential target for tumor immunotherapy
202152 citationsauthor #4
Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
20217 citationsauthor #8
Immune Profiling Reveals Molecular Classification and Characteristic in Urothelial Bladder Cancer
202110 citationsauthor #11
Predicting sulforaphane-induced adverse effects in colon cancer patients via in silico investigation.
202121 citationsauthor #9
Targeting neoantigens for cancer immunotherapy
20211 citationsauthor #4
m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning
202115 citationsauthor #2
m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
202147 citationsauthor #10
Corrigendum to "Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection treated cytokine-induced killer cells combined with chemotherapy in the treatment of malignancies" [Int. Immunopharmacol. 51 (2017) 57-65].
20210 citationsauthor #13
Identification of a ceRNA Network in Lung Adenocarcinoma Based on Integration Analysis of Tumor-Associated Macrophage Signature Genes
202112 citationsauthor #9
Tumor cell-derived CCL2 promotes chemoresistance via c-Fos in lung adenocarcinoma
20210 citationsauthor #10
CXCL11 Signaling in the Tumor Microenvironment.
202125 citationsauthor #2
m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer
202115 citationsauthor #11
Correction to: Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer
20211 citationsauthor #16
PD-1 Affects the Immunosuppressive Function of Group 2 Innate Lymphoid Cells in Human Non-Small Cell Lung Cancer
202126 citationsauthor #11
Contradictory roles of lipid metabolism in immune response within the tumor microenvironment
2021196 citationsauthor #8
Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
20212 citationsauthor #9
Targeting neoantigens for cancer immunotherapy
202136 citationsauthor #4
NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
202125 citationsauthor #13
Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models
202129 citationsauthor #11
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
202127 citationsauthor #10
Indoleamine 2,3-Dioxygenase 1 Inhibitor-Loaded Nanosheets Enhance CAR-T Cell Function in Esophageal Squamous Cell Carcinoma
202122 citationsauthor #7
Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
2021138 citationsauthor #12
Myeloid cells in COVID-19 microenvironment
202123 citationsauthor #5
Immuno‐oncological role of 20S proteasome alpha‐subunit 3 in aggravating the progression of esophageal squamous cell carcinoma
20216 citationsauthor #9
TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas
20210 citationsauthor #13
Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway
202027 citationsauthor #7
Correction: Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling
20200 citationsauthor #8
PD-1 abrogates the prolonged persistence of CD8+ CAR-T cells with 4-1BB co-stimulation
202013 citationsauthor #10
PD-1 upregulation enhances the immunosuppression of group 2 innate lymphoid cells by boosting IL-4 and IL-13 secretion in human non-small cell lung cancer
20200 citationsauthor #11
TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas
202037 citationsauthor #13
Gene modification strategies for next-generation CAR T cells against solid cancers
2020143 citationsauthor #4
Characterization of a non‐coding RNA‐associated ceRNA network in metastatic lung adenocarcinoma
20206 citationsauthor #14
Immune Characteristics Predict Outcome of Severe and Critical COVID-19 Patients
20205 citationsauthor #14
Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients
202059 citationsauthor #16
Immunosenescence: a key player in cancer development
2020382 citationsauthor #4
Metabolic Alterations Related to Glioma Grading Based on Metabolomics and Lipidomics Analyses
202029 citationsauthor #9
DEFB4A is a potential prognostic biomarker for colorectal cancer
202016 citationsauthor #11
PMN‐MDSCs‐induced accumulation of CD8+CD39+ T cells predicts the efficacy of chemotherapy in esophageal squamous cell carcinoma
20205 citationsauthor #10
COVID-19: immunopathogenesis and Immunotherapeutics
2020740 citationsauthor #8
Efficacy of cascade-primed cell infusion as an adjuvant immunotherapy with concurrent chemotherapy for patients with non-small-cell lung cancer: A retrospective observational study with a 5-year follow-up.
20203 citationsauthor #8
HMGB1 in inflammation and cancer
2020231 citationsauthor #2
L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma
202021 citationsauthor #13
Corrigendum to "Dynamic changes of CD45RA-Foxp3high T regulatory cells in chronic HCV patients during antiviral therapy" [Int J Infect Dis 45 (2016) 5-12].
20200 citationsauthor #10
Immune characteristics of severe and critical COVID-19 patients
202040 citationsauthor #10
T Cell Dysfunction and Exhaustion in Cancer
2020292 citationsauthor #6
Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling
202070 citationsauthor #19
Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy
202067 citationsauthor #8
Augmenting the Effectiveness of CAR-T Cells by Enhanced Self-Delivery of PD-1-Neutralizing scFv
202047 citationsauthor #7
Roles of IFN-γ in tumor progression and regression: a review
20202 citationsauthor #4
CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
202099 citationsauthor #7
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
2020468 citationsauthor #19
Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway
202010 citationsauthor #15
Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma
202083 citationsauthor #12
Chimeric Antigen Receptor T Cell Exhaustion during Treatment for Hematological Malignancies
202014 citationsauthor #3
EPHA5 mutation impairs natural killer cell-mediated cytotoxicity against non-small lung cancer cells and promotes cancer cell migration and invasion.
202017 citationsauthor #5
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma
202025 citationsauthor #21
Over-Expression and Prognostic Significance of HHLA2, a New Immune Checkpoint Molecule, in Human Clear Cell Renal Cell Carcinoma
202035 citationsauthor #10
Metformin Enhances the Antitumor Activity of CD8+ T Lymphocytes via the AMPK–miR-107–Eomes–PD-1 Pathway
2020120 citationsauthor #13
Abstract CT144: PD-1-CD28-enhanced receptor and anti-CD19 CAR-modified tumor-infiltrating T lymphocytes produce potential anti-tumor ability in solid tumors
20201 citationsauthor #5
Comprehensive Analysis of PD-1 Gene Expression, Immune Characteristics and Prognostic Significance in 1396 Glioma Patients
202017 citationsauthor #9
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
202047 citationsauthor #7
Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma
20201 citationsauthor #5
Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
2020350 citationsauthor #5
Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma [Retraction]
20200 citationsauthor #5
A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration
202062 citationsauthor #7
Roles of IFN-γ in tumor progression and regression: a review
2020966 citationsauthor #4
An Individualized Intra-Articular Stabilization Device Designed Based on 3D Printing Technology for Traumatic Instability of the Ulnohumeral Joint
20200 citationsauthor #2
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
2020587 citationsauthor #16
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma
202044 citationsauthor #10
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
201952 citationsauthor #8
Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma
201934 citationsauthor #14
Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC
2019171 citationsauthor #17
CD73: an emerging checkpoint for cancer immunotherapy.
2019106 citationsauthor #6
A cycle involving HMGB1, IFN-γ and dendritic cells plays a putative role in anti-tumor immunity.
201934 citationsauthor #15
The repertoire features of T cell receptor β-chain of different age and gender groups in healthy Chinese individuals.
201911 citationsauthor #18
The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas
201961 citationsauthor #18
CDR3 repertoire diversity of CD8+ T lymphocytes in patients with HCV.
20193 citationsauthor #5
Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
201954 citationsauthor #10
Significant Role of MCM10 in Lung Adenocarcinoma: Promote Viability and Migration
20190 citationsauthor #13
TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer
201980 citationsauthor #8

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT